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ABSTRACT
Motivation: Post-transcriptional and co-transcriptional regulation is a
crucial link between genotype and phenotype. The central players are
the RNA-binding proteins, and experimental technologies [such as
cross-linking with immunoprecipitation- (CLIP-) and RIP-seq] for prob-
ing their activities have advanced rapidly over the course of the past
decade. Statistically robust, flexible computational methods for bind-
ing site identification from high-throughput immunoprecipitation
assays are largely lacking however.
Results: We introduce a method for site identification which provides
four key advantages over previous methods: (i) it can be applied on all
variations of CLIP and RIP-seq technologies, (ii) it accurately models
the underlying read-count distributions, (iii) it allows external covari-
ates, such as transcript abundance (which we demonstrate is highly
correlated with read count) to inform the site identification process and
(iv) it allows for direct comparison of site usage across cell types or
conditions.
Availability and implementation: We have implemented our method
in a software tool called Piranha. Source code and binaries, licensed
under the GNU General Public License (version 3) are freely available
for download from http://smithlab.usc.edu.
Contact: andrewds@usc.edu
Supplementary information: Supplementary data available at
Bioinformatics online.
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1 INTRODUCTION
Originally thought simply to be a vehicle for the transport of
genetic information, RNA has come to be seen as a crucial
nexus for eukaryotic diversity and control of expression
(Licatalosi and Darnell, 2010; Sharp, 2009). The mechanisms
which govern this are diverse and include splicing, localization,
polyadenylation and the control of both transcript stability and
abundance. RNA-binding proteins (RBPs), which associate with
RNA through specialized protein domains called RNA-binding
domains, drive these processes. The activities of these proteins
can be complex and involve not only other proteins but also
other RNA species (Kedde et al., 2010; Kloosterman and
Plasterk, 2006; le Sage et al., 2007; Siomi and Siomi, 2009).
The functions of some RBPs are so essential that perturbation
of their activity can lead to remarkable phenotypic changes
(Che´nard and Richard, 2008; Lukong et al., 2008; Lunde et al.,
2007; Wang et al., 2010a).
Understanding the functions and mechanisms of the many
RBPs is one of the key challenges currently facing cellular biol-
ogy. Despite tremendous recent progress, there are still many
unanswered questions (Ko¨nig et al., 2012; Wang et al., 2010a).
Perhaps the most direct approach to profiling these interactions
is the immunoprecipitation of the RBP of interest through a
process similar in principle to chromatin immunoprecipitation
(ChIP). Modern high-throughput immunoprecipitation assays
for protein–RNA interaction can trace their lineage back to
RIP-chip, an array-based assay (Tenenbaum et al., 2000).
Cross-linking with immunoprecipitation (CLIP) extended upon
the success of RIP-Chip by introducing ultraviolet cross-linking
of the protein to the RNA and more stringent washing to in-
crease specificity, though potentially at the cost of reduced sen-
sitivity (Ule et al., 2005). More recently, CLIP has been coupled
with high-throughput sequencing (HITS-CLIP) to enable a much
greater range and depth of coverage (Licatalosi and Darnell,
2010). Further improvements to allow single-nucleotide reso-
lution have been achieved by iCLIP (Konig et al., 2010) and
photoactivatable-ribonucleoside-enhance CLIP (PAR-CLIP)
variants (Hafner et al., 2010).
There are substantial challenges to be overcome in terms of the
effective analysis of CLIP-seq data however. In this article, our
focus is on-site identification (or, peak-calling), which is the cru-
cial step that follows mapping of reads to a reference and deals
with identifying those genomic locations that are true protein
interaction sites. For simplicity, we refer to this step as site iden-
tification regardless of the resolution. That is to say, the process
may be as coarse-grained as calling target transcripts or as
fine-grained as identifying sites at a single-nucleotide level.
We begin by outlining three key challenges in RBP site iden-
tification. The first is intrinsic to the peak-calling process: many
sites to which reads map only receive a very small number of
reads and are likely noise. The levels of noise may be far from
negligible and have multiple causes. The sequenced sample may
contain RNA that has not been cross-linked to a protein or
alternatively that was cross-linked to some different protein,
but pulled down through antibody cross-reactivity. In addition,*To whom correspondence should be addressed.
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reads can map to non-target transcripts due to sequencing errors
or mapping problems. Effective use of the data requires separat-
ing these noise sites or false positives, from functional sites.
Most studies, explicitly or implicitly, assume read counts at in-
dividual sites, follow a particular distribution and use this distri-
bution to determine the probability of seeing a given number of
reads at a site by chance. However, there has been no large-scale
analysis of CLIP- and RIP-seq data to determine the most ap-
propriate choice of distribution to model these counts.
The second challenge is somewhat more esoteric. The propor-
tion of total reads falling in a given transcript does not give the
probability of that transcript being a target, but rather informs
the probability that a bound RNA is of that transcript. No know-
ledge of the number of unbound copies is available and hence the
RBPs preference for that transcript is not directly discernible.
This is true at higher resolutions also. Reads accumulate in tran-
scripts in proportion not only to the RBPs preference for that
transcript but also the transcript abundance. This is in contrast
to ChIP, where there is (in general) no variation in multiplicity
between different parts of the genome.
The final challenge we consider is that of incorporating exter-
nal information into the peak-calling process. There are a
number of types of external information, but here we consider
what is essentially control data. We give details of other external
information in Supplementary Material.
Previous studies involving CLIP-seq data have applied a range
of different approaches to site identification. Because of the high
fidelity of the CLIP assay, it is possible to side step the problem
and retain all sites (Licatalosi et al., 2008). This does not allow for
the filtering of noise interactions. Another simple approach is to
take the top n sites under some scoring, such as normalized read
count. This requires selecting a threshold, usually arbitrarily and
clearly prevents comparing the number of sites between RBPs
or conditions (Hafner et al., 2010; Kishore et al., 2011). More
sophisticated methods employ a simulation of the CLIP-seq
experiment assuming no site-specific preference and use this
to arrive at a false discovery rate for any given peak height
(Chi et al., 2009; Konig et al., 2010; Leung et al., 2011;
Yeo et al., 2009). Although this allows for consideration of tran-
script abundance, there is no mechanism to explicitly adjust for
other sequencing biases and the approach is not applicable to
situations, where a second condition or control is available
(e.g. RIP-seq).
Finally, some site identification methods intrinsically consider
information specific to a particular immunoprecipitation assay
(Corcoran et al., 2011; Hafner et al., 2010; Lebedeva et al., 2011;
Zhang and Darnell, 2011). Although these have been highly suc-
cessful, they cannot be applied in the more general setting.
Several databases of CLIP-seq data also exist, for example
CLIPZ, StarBase and doRiNA (Anders et al., 2012; Khorshid
et al., 2011; Yang et al., 2011). The latter two focuses on
microRNA (miRNA)–RBP interactions. CLIPZ and StarBase
group reads into clusters but do not perform any further site
identification. In contrast, doRiNA uses a site identification
strategy for PAR-CLIP that relies upon T to C conversions at
the cross-link site, but is unable to automatically score or rank
sites from RIP-seq or other CLIP-seq variants.
We present a method for site identification that is applicable
across the three commonly used CLIP-seq variants and in add-
ition can be applied to RIP-seq data (for which, to our know-
ledge, no peak-calling tools currently exist). Our method
addresses each of the three challenges outlined earlier: effectively
modeling the underlying distribution, utilizing transcript abun-
dance information and flexibly allowing the incorporation of
external data. Further, we demonstrate how such a tool can be
applied to answer more advanced biological questions regarding
RBP binding sites that vary in usage between different cell types,
conditions or stages of development.
Table 1. We assembled a large collection of CLIP- and RIP-Seq datasets representing 22 distinct RBPs, 6 cell types and 4 technologies (iCLIP,
HITS-CLIP, PAR-CLIP and RIP-Seq)
RBP Technology Cell Citation
Ago HITS-CLIP HeLa Chi et al. (2009)
Ago{1 . . . 4}, IGF2BP{1 . . . 3}, PUM2, QKI, TNRC6{A . . .C} PAR-CLIP HEK293 Hafner et al. (2010)
HnRNPH HITS-CLIP HEK293 Katz et al. (2010)
Ago2, HuR HITS-CLIP, PAR-CLIP HEK293 Kishore et al. (2011)
Fox2 HITS-CLIP hESC Yeo et al. (2009)
hnRNPC iCLIP HeLa Konig et al. (2010)
HuR PAR-CLIP HeLa Lebedeva et al. (2011)
HuR PAR-CLIP HEK293 Mukherjee et al. (2011)
HuR iCLIP HeLa Uren et al. (2011)
Ago2 HITS-CLIP mESC Leung et al. (2011)
TIA1, TIAL1 iCLIP HeLa Wang et al. (2010b)
PTB HITS-CLIP HeLa Xue et al. (2009)
TDP43 HITS-CLIP Mouse brain Polymenidou et al. (2011)
TDP43 iCLIP SH-SY5Y Tollervey et al. (2011)
Nova HITS-CLIP Brain Zhang et al. (2010)
Ago2 HITS-CLIP HEK293 This publication
hTra2 RIP-seq HeLa This publication
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2 METHODS
2.1 Data
We compiled all CLIP-seq (HITS, iCLIP and PAR-CLIP) datasets that
were publicly available at the time of writing (see Table 1). In addition,
we analyzed a previously unpublished HITS-CLIP dataset for Ago2/
miR-124 and a RIP-seq dataset for hTra2, which we briefly describe.
For the identification of miR-124-guided Ago2 binding sites by CLIP,
5 cm 15 cm plates of 293S cells at 70% confluency per condition/repli-
cate were used. Cells were transfected for 24hwith 100nMmir-124 siRNA
(50-UAAGGCACGCGGUGAAUGCCA-30 and 50-GCAUUCACCGC
GUGCCUUACA-30 duplex) or control gl3.1 siRNA (50-CUUAC
GCUGAGUACUUCGAUU-30 and 50-UCGAAGUACUCAGCGUA
AGUU-30 duplex) using Mirus Trans-IT TKO. The CLIP procedure
was carried out by a modified protocol of Chi et al. (2009) as described
in Supplementary Material.
The RIP protocol used for hTra2 is as follows: 400ml of Protein A
sepharose (50% slurry) was washed five times with NT2 buffer (50mM
Tris–HCl pH 7.4, 1M Tris–HCl, 150mM NaCl, 1mM MgCl2, 0.05%
NP40) and resuspended in 1ml of NT2 plus 5% BSA and 10mg of rabbit
anti-hTRA2B (Abcam) or normal rabbit IgG. Beads plus antibodies were
incubated overnight at 4C with rotation and washed five times with cold
NT2 buffer. Lysates were prepared from semi-confluent HeLa cells in
polysomal lysis buffer (10mM HEPES pH 7.0, 100mM KCl, 5mM
MgCl2, 0.5% NP40, 2mM dithiothreitol) containing proteinase and
RNA inhibitors. After centrifugation for 10min, supernatant was
adjusted to 2mg/ml and 6ml of lysate were combined with the bead/
antibody and rotated at room temperature for 3–5h. Beads were
washed five times with cold NT2. After last wash samples were digested
with RNase III; 4ml of RNaseIII (Ambion) were combined with 600ml of
1 buffer, added to samples and incubated for 30min at 37C with agi-
tation. Beads were recovered by centrifugation and washed three times
with NT2 buffer. Proteins were extracted with 25ml (20mg/ml) proteinase
K in 600ml of 1 buffer at 50C for 30min. Samples were vortexed for
1min and beads pelleted by centrifugation. The supernantant was ex-
tracted with 700ml of acid phenol–chloroform and precipitated with
sodium acetate and isopropanol. RNA was recovered by centrifugation,
washed and resuspended in 13ml of RNase free water. Quantity and
quality were checked with Nanodrop and Bioanalyzer. Fifty nanograms
of RNA were amplified using Nugen Ovation RNA-seq System I and
libraries prepared with the Nugen Encore NGS Library System I per
manufacturer’s protocol.
To adjust for transcript abundance, we also make use of RNA-seq
data for HeLa cells (Uren et al., 2011) and HEK293 cells. All previously
unpublished sequence data have been deposited into the sequence
read archive (SRA), accession numbers: SRA056343, SRA056308,
SRA056344.
2.2 Pre-processing
For each dataset, we trimmed adapters and mapped to an appropriate
reference genome (full genome—hg19 or mm9) and junction database
using rmap (Smith et al., 2009). Transcripts were defined per the
University of California Santa Cruz (UCSC) genome browser known-
genes track. We allowed up to three mismatches when mapping and re-
tained only reads that unambiguously mapped to a single location.
Junction reads were split and assigned to both side of the junction.
Full details of the mapping results are given in Supplementary
Material. Our method does not depend on any particular mapping or
pre-processing strategy. Research is ongoing with respect to the most
effective methods for mapping RNA reads and will be further spurred
on as immunoprecipitation-based assays are paired with emerging
sequencing platforms promising longer read lengths. Coupled with an
effective choice of mapping and pre-processing techniques, our site iden-
tification method will remain relevant.
2.3 Peak finding
The input for site identification is a set of reads mapped to the reference
genome. All reads are binned based on the nucleotide at which they
begin. A bin represents a genomic interval and can be single nucleotide
in width. Appropriate choice of bin size is dependent on depth of cover-
age and technology used (see Section 3.3). Let yi be the count of the
number of reads which start in the ith bin. Each bin optionally has an
associated vector of covariates, which we denote xi
!. A covariate is a
measure of some property that is expected to vary in parallel with the
immunoprecipitation read counts, but need not be count data. An ex-
ample is mappability of the bin, a measure of how many locations within
the bin start sequences of length equal to the read length, which are not
duplicated elsewhere in the genome and hence can be non-ambiguously
mapped to. Bins with low mappability are expected to correlate
with lower read count. We model the read counts within bins using
a zero-truncated negative binomial distribution (see Section 3.2 for justi-
fication). Read counts from high-throughput immunoprecipitation
experiments are Poisson over-dispersed. The negative binomial is an ap-
propriate choice of distribution for dealing with Poisson over-dispersion,
but does not correctly handle the adjusted weight for zero observations.
One option is to use the zero-inflated negative binomial, as was adopted
by the zero-inflated negative binomial algorithm (ZINBA) for peak call-
ing in ChIP-seq data (Rashid et al., 2011). However, the zero-inflated
negative binomial assumes a mixture, where a certain number of zeros are
drawn from the negative binomial component (and the remainder from
the zero-inflated component); this does not genuinely reflect the true
underlying distribution, which does not produce zeros. Moreover, the
additional complexity makes model fitting more difficult and time con-
suming. Instead, we retain only those bins with one or more reads map-
ping. We discuss this further in Supplementary Material. The zero-
truncated negative binomial (ZTNB) has the following log-likelihood
function:
Lðj, yÞ ¼ LNBðj, yÞ

Xn
i¼0
ln 1 ð1þ Þ1
 
,
ð1Þ
where m is the (un-truncated) mean,  is the dispersion parameter and
LNBðj, yÞ is the log-likelihood of the non-adjusted negative binomial,
that is
LNBðjy,Þ ¼
Xn
i¼0
yi ln

1þ 
 

1 lnð1þ Þ þ ln yi þ 1
 
 lnðyi þ 1Þ  ln 1
 
:
ð2Þ
We fit the model by finding the maximum likelihood estimates for m
and . We assume that the majority of sites with reads are low-occupancy
or noise sites (see Section 3.2 for details and justification) and so the fit
model represents a background. At an abstract level, our method is
modeling the read-count distribution of the dataset, which is an accept-
able proxy for the background noise distribution. We then look for lo-
cations with read counts that are unexpectedly large based on this
theoretical distribution. To do this, after model fitting, each bin is as-
signed a P-value by subtracting from 1 the sum of densities for all values
less than the read count associated with that bin. Significant bins can then
be selected by a P-value threshold; the smaller the P-value, the more
unlikely the read count in the bin is given the fit distribution.
When additional external data (covariates) are available, we use a
zero-truncated negative binomial regression (ZTNBR) model (Cameron
and Trivedi, 2008; Hilbe, 2011). Briefly, this requires replacing the scalar
parameter m with a vector ~, where each i ¼ expð ~T xi!Þ and ~ is the
vector of regression coefficients. The model is fit using a Newton–
Raphson algorithm for the estimation of the regression parameters and
3015
Site identification in high-throughput RNA–protein interaction data
 at Cold Spring H
arbor Laboratory on M
ay 2, 2013
http://bioinform
atics.oxfordjournals.org/
D
ow
nloaded from
 
a dispersion dampening algorithm for estimating  (Hilbe, 1993, 2011).
Each bin is assigned a P-value in the same way as previously described. A
short illustration of applying the regression model to calculate P-values is
given in Table 2. Notice how large read counts do not necessarily lead to
significant P-values. A full description of the model, its derivation and
fitting is provided in Supplementary Material.
2.4 Implementation and post-processing
Our method has been implemented in a software tool called Piranha.
When no covariates are provided, it will fit a ZTNB model. If covariates
are provided, it will fit a ZTNBR model. Input may be either raw reads in
browser extensible data (BED) or binary sequence alignment/map
(BAM) format, or pre-binned read counts in BED format. Covariates
are provided in BED format. Output is in an extended BED format,
where an additional column gives the P-value. The implementation and
instructions for its use are given at http://smithlab.usc.edu
For the analysis in this article, we adjust output P-values to correct
for multiple hypothesis testing using the method of Benjamini and
Hochberg (1995).
3 RESULTS AND DISCUSSION
3.1 Alternative methods
Two recent approaches have been proposed specifically for
addressing the problem of site identification in CLIP-seq data
(Corcoran et al., 2011; Zhang and Darnell, 2011). Zhang’s
method works on HITS-CLIP data and employs cross-linking-
induced mutation sites (CIMS, primarily deletions) to refine site
location, while PARalyzer is designed for PAR-CLIP data and
relies on T to C conversions at the cross-link site. In contrast, the
method we propose works on all CLIP-seq variants (iCLIP,
PAR-CLIP, HITS-CLIP), as well as RIP-seq, while still being
able to consider the positional deletion and mutation informa-
tion used in these two methods as covariates. Further, our
method allows the consideration of additional covariates (such
as transcript abundance, which we demonstrate impacts read
counts considerably). Moreover, Zhang et al. (2010) found that
deletion events occur only in8–20% of mRNA tags, meaning a
substantial proportion of reads would not be informative, while
our method can take advantage of all the mapped reads in each
study. PARalyzer is publicly available and we compare its per-
formance to our method (details of usage are in Supplementary
Material); The CIMS-based method has no public implementa-
tion at the time of writing.
3.2 Read counts follow a zero-truncated negative binomial
distribution
For each dataset, we estimated the parameters of a zero-
truncated Poisson, negative binomial and zero-truncated nega-
tive binomial distribution for the counts when binned at
single-nucleotide resolution. Figure 1A and B shows visually
the improved fit provided by the ZTNB when compared to the
NB; both panels show the average density of the real data in red
and all of the fit densities for the NB and ZTNB in blue and
green, respectively. To validate the improvement seen visually in
Figure 1A and B we conducted a set of Pearson’s 2 tests. For
90.8% (109 of 120) of the datasets, the Pearson’s 2 test showed
that the zero-truncated negative binomial provides a superior
fit to a Poisson, zero-truncated Poisson or regular negative
binomial distributions (see Fig. 1C for an example and
Supplementary Table S2 for the complete set of results from
the 2 tests). The majority of sites with reads mapping are
low-occupancy or noise sites (Fig. 1D); in most of the datasets
analyzed,480% of locations with reads mapping saw55 reads.
Theoretically, read counts at sites are a mixture, with some
drawn from a foreground distribution and some from a back-
ground noise distribution. In practice, though the mixing param-
eter is so heavily weighted toward the background that
parameter estimates for the whole data closely approximate the
background component. This is one reason that we eschew
fitting a mixture and instead prefer the simpler single
distribution.
Table 2. Example of calculating P-values for bins using the ZTNBR with two covariates: mappability (X1, in arbitrary units) and transcript abundance
(X2, in reads mapped from RNA-seq control), assuming the model has already been fit with ¼ 0.17, 0.02 and ¼ 2
Y X1 X2 expð ~T xi!Þ ¼  P-value
1 4 10 exp(0.17 4þ 0.02 10)¼ 2.41 1P1
j¼1
Pr(yi¼ j jm¼ 2.41, ¼ 2)¼ 0.71
3 2 37 exp(0.17 2þ 0.02 37)¼ 2.94 1P3
j¼1
Pr(yi¼ j jm¼ 2.94, ¼ 2)¼ 0.45
250 5 30 exp(0.17 5þ 0.02 30)¼ 4.26 1P250
j¼1
Pr(yi¼ j jm¼ 4.26, ¼ 2)58.63 1014 ***
5 4 17 exp(0.17 4þ 0.02 17)¼ 2.77 1P5
j¼1
Pr(yi¼ j jm¼ 2.77, ¼ 2)¼ 0.27
7 7 13 exp(0.17 6þ 0.02 13)¼ 3.60 1P7
j¼1
Pr(yi¼ j jm¼ 3.60, ¼ 2)¼ 0.24
300 10 180 exp(0.17 10þ 0.02 180)¼ 200.34 1P300
j¼1
Pr(yi¼ j jm¼ 200.34, ¼ 2)¼ 0.23
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3.3 Read count is correlated with transcript abundance
The most common approach for site identification is a threshold.
Applying a single threshold across the whole transcriptome is
problematic since it does not consider transcript abundance.
To quantify this, we compared RNA-seq data from HeLa and
HEK293 to those IP experiments conducted in these cell lines.
We observed a substantial positive correlation between RNA-seq
read counts for a transcript and IP read counts (see Fig. 2A for
the distribution of correlation coefficients and Fig. 2B for an
example dataset), with an average correlation coefficient of
0.36 over the 85 datasets examined. We also compared 200nt
bins (see Fig. 2C) to ascertain the extent to which this relation-
ship holds at a more fine-grained level. Here, we observed a
lesser, but still substantial degree of correlation, with an average
correlation coefficient of 0.16.
To address the problem of varying transcript abundance, we
incorporate an RNA-seq control into our peak calling by supply-
ing it as a covariate for the ZTNB regression method of Piranha.
For this analysis, we considered a bin size of 200 nt, as was used
earlier. An appropriate choice of bin size is dependent on the
technology used and sequencing depth. Here, we have opted to
select a bin size that allows us to capture the correlation between
IP and RNA-seq given the level of coverage we have and is gen-
erally appropriate across all of the technologies profiled.
The number of experimentally verified binding sites for any
given RBP is currently too low to realistically be used as a gold
standard for peak calling. Instead, we turn to motif enrichment
as a measure of accuracy—a similar approach was taken by
Zhang and Darnell (2011). To be agnostic of existing character-
izations of an RBPs motif, we perform de novo motif discovery
for each dataset and consider the top enriched motif to be the
A
C
B
Fig. 2. CLIP- and RIP-seq read counts are correlated with transcript abundance. (A) Distribution of Spearman correlation coefficients for RNA-seq and
immunoprecipitation read counts at transcript level over all examined datasets shows frequent strong correlation (B) Example hexbin plot showing
transcript-level correlation between IP read count for HuR (selected at random from the set of highly correlated datasets; data from Mukherjee et al.,
2011) and RNA-seq read count in HEK293 cells. Spearman correlation coefficient: 0.67 (C) As in (A), but with 200nt-wide non-overlapping bins;
correlation is reduced in smaller bins, but still present
A B C D
Fig. 1. CLIP read counts are fit well by zero-truncated negative binomial. (A) The average read count density for all datasets is shown in red (error bars
are 95% confidence interval). The fitted densities for a negative binomial on all of the datasets is shown in blue (note that all densities are shown, rather
than an average for each read count). Only read counts520 are shown. (B) As with (A), but replacing the fit densities from the negative binomial with
those of a zero-truncated negative binomial distribution. (C) Histogram of read counts from an iCLIP experiment for TIA1 (Wang et al., 2010b) showing
fit zero-truncated Poisson, negative binomial and zero-truncated negative binomial distributions. (D) Histogram showing the count of datasets for which
80% of the locations receiving reads have no more reads than the given count; the majority of datasets have480% of their locations with55 reads.
Four outliers are not shown, with read counts of 79, 93, 88 and 228
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correct one. For motif discovery, we use the DME algorithm
(Smith et al., 2005). Full details of the scoring method used are
given in Supplementary Material. We observed an average
11.6% improvement in motif score on the examined datasets
when using the ZTNBR with RNA-seq covariate over the regu-
lar ZTNB (P55.9 103, Wilcoxon test), demonstrating that
inclusion of this additional data can improve site identification.
We compared the performance of our method to PARalyzer,
the only other publicly available site identification tool for
CLIP-seq data. On PAR-CLIP datasets (which it is designed
for), PARalyzer scores are on an average 3% better than
ZTNB; however, the difference is not statistically significant.
On an average the ZTNBR with transcript abundance covariate
scores 17.2% higher (P50.002, Wilcoxon test). Full details are
given in Supplementary Material.
3.4 Incorporating general external information
3.4.1 Using non-specific antibody controls in RIP-seq
data RIP-seq is not as specific as CLIP-seq, but is a more sen-
sitive assay. An additional immunoprecipitation experiment
using a non-specific antibody acts as a control. The appropriate
use of this control in a statistically sound and robust fashion is
essential for site identification in RIP-seq data; to our know-
ledge, no tools currently exist for this task. Piranha is able to
use the non-specific antibody control as a covariate when calling
peaks.
We applied our method to a RIP-seq dataset for hTra2, a
ubiquitously expressed member of the serine/argenine-rich pro-
tein family. hTra2 functions as a splicing regulator, with its ab-
errant activity implicated in several diseases (Cle´ry et al., 2011;
Gabriel et al., 2009; Hirschfeld et al., 2009; Hofmann et al., 2000;
Sumner, 2007; Tsuda et al., 2011). The canonical hTra2 binding
site is the (GAA)2 repeat (Tsuda et al., 2011).
We provide the non-specific antibody control as a covariate to
our zero-truncated negative binomial regression method. After
selection of those sites which are significant, we performed
de novo motif detection. The top identified motif enriched
around the sites we identified is a match for the previously
known (GAA)2 motif and shows preferential localization near
significant RIP-seq sites (see Fig. 3A). To determine whether the
use of the non-specific antibody improves performance, we also
ran Piranha without this extra input. Although the motif found
is the same, we observe an increased occurrence around
sites identified when using the non-specific antibody control.
This demonstrates that our peak-calling tool can successfully
be applied not only to CLIP-seq but also RIP-seq data. Full
details of the hTra2 analysis, including identified sites, are
given in Supplementary Material.
3.4.2 Identification of differentially used binding sites Another
challenge is the identification of sites which are differentially
bound between tissue types or conditions. Our method allows
for such a comparison by considering read counts in the first
tissue/condition as a covariate of the second. Bins receiving sig-
nificantly low P-values are enriched for binding in the second
tissue/condition relative to the first. We applied this idea to a
HITS-CLIP dataset for the RBP Ago2, which is part of a ribo-
nucleoprotein complex that is predominantly MiRNA targeted.
We transfected HEK293 cells with miR-124 (which is not en-
dogenously expressed) and identify its targets by a comparison
against non-transfected cells. We applied our method to this
dataset (see Supplementary Material for full details) and identi-
fied a set of 318 locations enriched for binding upon miR-124
transfection (false-discovery-rate-corrected P50.05). This is
comparable to the number of genes found to be down-regulated
by Lim et al. (2005) upon transfection of miR-124. Performing de
novo motif search on windows of 800 bp (400 upstream and 400
downstream) of these sites identified the motifs in Figure 3B. Our
method identifies sites which are enriched for sequences that are
complementary to the miR-124 sequence, supporting these as
true miR-124 target sites. Further, the matching motifs are
A
C
B
Fig. 3. (A) Top identified motif and motif occurrence histogram for hTra2 identified from RIP-seq data using ZTNBR with non-specific control (red)
and using ZTNB with no control (blue). (B) The top six enriched motifs and their positional occurrence histograms from the HITS-CLIP Ago2/miR-124
data. All motifs match to the miR-124 reverse-complement. Seed highlighted in red. (C) Number of target sequences in Ago2/miR-124 with a match to
any 7-mer from the reverse-complement miR-124 sequence. One nucleotide miss-match was allowed. Blue box: 164 sites (51.2%) contain a match within
90nt of the peak centre
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positionally enriched around the cross-link sites, supporting their
functional importance. Finally, we also show in Figure 3C the
number of sites that have a match to any 7-mer from the
miR-124 complement around the identified sites; more than
half the sites have a match within 45 nt of the peak centre.
We compared this approach to simply calling sites separately
in each condition using the ZTNB (without covariates) and
then taking those sites which are significant in the miR-124 trans-
fection, but not in the control. Using this approach, the top
six enriched motifs match miRNAs other than miR-124; none
of them is a match for miR-124. Further details are in
Supplementary Material.
Although here we have applied this to the problem of miRNA
target site identification, the same approach could be used
to identify differentially bound sites in any conceivable pair of
tissues or conditions, an exciting research direction that promises
to further expand our understanding of how RBPs participate in
cell-fate determination and pathogenesis or for exploring RBP
evolution by comparing across species.
4 CONCLUSION
HITS coupled with immunoprecipitation assays have provided
an unprecedented level of accuracy in identifying the targets and
binding sites for RBPs. Despite this, the data collected from such
experiments require some considerable care to extract the most
meaningful information from it. Within this article, we have
highlighted three challenges that are presented when attempting
to identify protein–RNA interactions sites in high-throughput
immunoprecipitation sequencing data: selecting the correct dis-
tribution for modeling reads, dealing with the transcript abun-
dance bias and incorporating additional external information
into the peak-calling process.
We introduced Piranha, a peak-calling tool based on the
zero-truncated negative binomial regression model that is able
to incorporate external information to guide the site identifica-
tion process. We demonstrated that transcript abundance influ-
ences the read counts at sites in IP datasets, that Piranha can
successfully incorporate RNA-seq control data to ameliorate this
bias and that by considering this additional information, more
accurate peak calls are arrived at. We also showed that our
method can be applied across all of the currently existing
CLIP-seq technologies and also handles the more complex case
of RIP-seq data. Finally, we also demonstrated Piranha’s appli-
cation to more complex biological questions involving multiple
cell types, conditions, stages of development or species.
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